The value of molecular monitoring for residual disease (MRD) in early morphological remitters among adults diagnosed with B cell ALL and treated according to the MRC UKALL12 protocol.

The value of molecular monitoring for residual disease (MRD) in early morphological remitters among adults diagnosed with B cell ALL and treated according to the MRC UKALL12 protocol.

Détails bibliographiques
Auteurs principaux: Foroni, L, Mitchell, W, Rai, L, Richards, S, Fielding, A, Goldstone, A
Format: Conference item
Publié: 2005

Documents similaires